PGD extension letter – Repevax and Infanrix
The current Patient Group Direction (PGD) for the pre-school booster (combined diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine (Repevax and Infanrix IPV vaccines) – NECSAT 2014/014) expires on 31st August 2016.
In order for the approval process to be completed appropriately it has been necessary to extend the authorisation of the PGD for 2 months, until the new PGD is issued.
The attached letter authorises and extends the validity of the Repevax and Infanrix PGD to continue to be valid and used until 31st October 2016, unless replaced earlier.
Combined diphtheria, tetanus, acellular pertussis and inactivated polio and Hib vaccine (DTaP/ IPV/ Hib - Pediacel and Infanrix IPV + Hib) (1313 downloads)
The Patient Group Direction (PGD) for Combined Diphtheria, Tetanus, Acellular Pertussis and Inactivated Polio plus HIB Vaccine (DTaP/IPV/Hib – PEDIACEL and Infanrix IPV + Hib) has been updated and is available to download.
The new PGD has been jointly developed and authorised by North of England Commissioning Support (NECS) and NHS England (Cumbria and North East) for use by practices and NHS services within the Durham, Darlington, Tees, Cumbria, Northumberland and Tyne & Wear areas. This new PGD reflects the most up to date recommendations and have been produced to support the national immunisation programme and replaces all previous versions.
It is advisable to take a master copy of the blank PGD to keep on file should you need it for a newly appointed nurse. I would be grateful if you could ensure that this PGD is read, agreed and signed by all nurses it applies to.
For each practice nurse PGDs should be authorised by the clinical lead on behalf of the practice. Once completed, a copy of the management & monitoring form should be given to each nurse, with the original practice copy being kept on file by the practice (in your Clinical Governance Handbook). Replaced PGDs should be filed and kept as a record of practice.
All current PGDs can be found at https://medicines.necsu.nhs.uk/resources/patient-group-directions/
The current Patient Group Directions for Boostrix-IPV, Pneumococcal (PPV and PCV) and Hib/MenC have been updated.
The new PGDs have been jointly developed and authorised by NECS and NHS England for use by practices and services within the Durham, Darlington, Tees, Cumbria, Northumberland and Tyne & Wear areas. These new PGDs reflect the most up to date recommendations and have been produced to support the national immunisation programme and replace all previous versions.